Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone morphogenetic protein receptor type-1A (BMPR1A) is a transmembrane serine/threonine kinase receptor that plays a critical role in the bone morphogenetic protein (BMP) signaling pathway, which is part of the larger transforming growth factor beta (TGF-β) superfamily. It functions as a cell surface receptor for several ligands, including BMP2, BMP4, GDF5, and GDF6, regulating osteoblast function, chondrocyte differentiation, and adipogenesis. Mutations or dysregulation in BMPR encoding genes are implicated in various diseases involving abnormal tissue development or homeostasis.
Ligand-induced assembly of heteromeric complexes between type I (such as BMPR1A) and type II BMP receptors at the plasma membrane. Type II kinases activate type I kinases through phosphorylation; activated BMPRIA then propagates signals primarily through phosphorylation of SMAD proteins that modulate gene transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone Morphogenetic Protein Receptor Type-1A (BMPR1A).